1356152-70-9Relevant academic research and scientific papers
IMPROVED SOLUBILITY FOR TARGET COMPOUNDS
-
, (2017/03/21)
The present disclosure relates to compounds having an improved solubility thereby increasing their bioavailability, lower dosages, etc. The target compounds, may include but are not limited to, macrophage migration inhibitory factor (MIF) inhibitors, epid
MIF INHIBITORS AND THEIR USES
-
Paragraph 1023, (2015/03/16)
The invention relates to MIF inhibitors; compositions comprising an effective amount of a MIF inhibitor; and methods for treating or preventing diseases associated with MIF.
MIF INHIBITORS AND THEIR USES
-
, (2012/02/02)
The invention relates to MIF inhibitors; compositions comprising an effective amount of a MIF inhibitor; and methods for treating or preventing diseases associated with MIF.
